Abstracts

When Diagnosing HAND, Should Visuospatial Functioning be Evaluated?

Background: Prior research has demonstrated that visuospatial functioning is often deleteriously affected in HIV-Associated Neurocognitive Disorders (HAND). Nevertheless, tests of visuospatial abilities are often omitted in current HAND research. We sought to determine whether the addition of visuospatial measures to an established HIV neuropsychological battery would increase the rate of HAND diagnoses. Additionally, to determine…

Predictors of Neurocognitive Decline Among Aviremic Individuals in the CHARTER Cohort

Background: Limited information is available on the predictors of neurocognitive (NC) decline in individuals with good virological control. Identification of modifiable risk factors that predict decline would support the development of targeted interventions aimed at minimizing NC decline in higher-risk individuals. The objective of the study was to identify baseline factors predicting NC decline over…

Association Between Plasma Homocysteine Levels and Neuronal Injury in Untreated HIV

Background: Many HIV-1 infected patients without antiretroviral treatment suffer from neurological symptoms in a varying range of severity. Most patients with, and several without, neurological symptoms have elevated levels of neurofilament light protein (NFL) in cerebrospinal fluid (CSF), a marker of ongoing axonal injury. Hyperhomocysteinemia, related to vitamin B12 and folic acid deficiency, is associated…

Plasma MicroRNA Profiling Predicts HIV-Associated Neurocognitive Disorder

Background: HIV-associated neurocognitive disorder (HAND) is common, affecting 30-50% of HIV-infected patients despite the availability of effective antiretroviral therapy. The development of HAND is influenced by several factors including altered host and viral gene expression. Host-encoded microRNAs (miRNAs) regulate both host and viral gene expression. Thus, host miRNAs could contribute to the pathogenesis of HAND…

Performance of 4 Tools to Screen for HIV-Associated Cognitive Impairment

Background: A high prevalence of mild cognitive impairment (CI) has been reported in HIV-infected individuals on combination antiretroviral therapy (cART). An accurate screening tool would be useful to identify those at risk of HIV-associated CI who should undergo neuropsychological assessment (NPA). We assessed diagnostic characteristics of four often advocated screening tools: Mini Mental State Examination…

Astrocyte and Microglial Activation in Acute and Chronic HIV Pre- and Post-cART

Background: Cerebrospinal fluid (CSF) YKL-40, a putative marker of astrocyte and microglial activation associated with Alzheimer’s disease and multiple sclerosis, is a potentially useful biomarker of processes occurring within the central nervous system (CNS) of HIV-infected individuals. To explore the impact of early HIV infection and early versus later initiation of combination antiretroviral therapy (cART)…

CNS Immunoactivation and Neuronal Damage in Patients With Progressive Neurocognitive Impairment

Background: Although HIV-associated neurocognitive disorders (HAND) remain prevalent, the clinical significance is unclear. A recent report indicates a higher risk of symptomatic progression in subjects with asymptomatic neurocognitive impairment (ANI) than in unimpaired subjects. In a previous cross sectional analysis, we found that subjects with neurocognitive impairment (NCI) had increased cerebrospinal fluid (CSF) levels of…

Endothelial Function and CNS Measures in Primary HIV Infection Pre and Post Early ART

Background: HIV infection, vascular perturbation, and central nervous system (CNS) dysfunction may associate through common pathogenic pathways of inflammation observed even in antiretroviral therapy (ART)-controlled HIV infection. We examined plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor and biomarker of endothelial dysfunction in participants recruited during primary HIV infection (PHI, <…

Platelet-Endothelial Interactions in SIV-Associated CNS Disease

Background: Platelet decline is associated with increased risk for the development of HIV-associated neurocognitive deficits. Interaction of activated platelets with brain microvascular endothelium may contribute to platelet decline and directly influence the permeability of the blood brain barrier. We sought to determine whether these interactions occur in the SIV-infected pigtailed macaque model of HIV-associated CNS…